MedPath

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

Phase 1
Conditions
Prematurity
Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Registration Number
CTIS2023-509780-25-00
Lead Sponsor
niversity College Cork
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
700
Inclusion Criteria

Infants with gestational age between 23 to 28 weeks based on best available obstetrical estimate, Infants designated to receive full resuscitation, i.e., no parental request or pre-determined decision to forego resuscitation, No known major congenital or chromosomal malformation.

Exclusion Criteria

Infant born outside of study centers and transported to center after delivery, Parents’ refusal to give consent to this study

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath